A major breakthrough in cancer study is occurring with the use of mini-antibodies to re-engage damaged p53. This essential cancer protector protein is frequently disabled in several kinds of tumors, resulting https://bookmarkextent.com/story24146619/nanobodies-reactivate-tumor-suppressor-p53-new-potential-hope-for-malignant-therapy